BIIB - Biogen named a best idea for 2024 at Cowen
2023-12-07 15:13:39 ET
More on Biogen
- Biogen: LEQEMBI's $10 Billion Potential
- Biogen Inc. (BIIB) Evercore ISI 6th Annual HealthCONx Conference (Transcript)
- Biogen's Uncertain Strategic Pivots Amidst MS Market Challenges
- Ionis says Angelman syndrome drug well tolerated in study
- Biogen swings to Q3 growth after Reata acquisition (update)
For further details see:
Biogen named a best idea for 2024 at Cowen